Blockade of the pore-forming P2X7 receptor inhibits formation of multinucleated human osteoclasts in vitro
about
Molecular and functional properties of P2X receptors--recent progress and persisting challengesPolymorphisms in the P2X7 receptor gene are associated with low lumbar spine bone mineral density and accelerated bone loss in post-menopausal womenP2X7 receptors regulate multiple types of membrane trafficking responses and non-classical secretion pathwaysPurinergic signalling in boneReduced bone turnover in mice lacking the P2Y13 receptor of ADP.Adenosine and bone metabolism.Trophic activity of human P2X7 receptor isoforms A and B in osteosarcoma.Single-nucleotide polymorphisms in the P2X7 receptor gene are associated with post-menopausal bone loss and vertebral fracturesAssociation between P2X7 Receptor Polymorphisms and Bone Status in Mice.Genetic Background Strongly Influences the Bone Phenotype of P2X7 Receptor Knockout MiceP2X7 Receptor Function in Bone-Related Cancer.Functional polymorphisms in the P2X7 receptor gene are associated with stress fracture injury.Expression, signaling, and function of P2X7 receptors in bone.Purinergic signalling in the musculoskeletal system.Short- and long-term (trophic) purinergic signalling.Atypical P2X receptor pharmacology in two human osteoblast-like cell lines.Expression of the P2X7 receptor increases the Ca2+ content of the endoplasmic reticulum, activates NFATc1, and protects from apoptosis.Quantitative structure-activity relationship study of P2X7 receptor inhibitors using combination of principal component analysis and artificial intelligence methods.P2 receptors in macrophage fusion and osteoclast formation.The P2X7 Receptor is an Important Regulator of Extracellular ATP Levels.The effects of P2X7 receptor antagonists on the formation and function of human osteoclasts in vitro.Role of the P2X7 receptor in the osteogenic differentiation of mesenchymal cells and in osteoclast fusion : presented by: Maria P. Abbracchio.Purinergic P2X7 receptor functional genetic polymorphisms are associated with the susceptibility to osteoporosis in Chinese postmenopausal women.Understanding the tissue effects of tribo-corrosion: uptake, distribution, and speciation of cobalt and chromium in human bone cells.Genetic interaction of purinergic P2X7 receptor and ER-α polymorphisms in susceptibility to osteoporosis in Chinese postmenopausal women.Emodin regulates bone remodeling by inhibiting osteoclastogenesis and stimulating osteoblast formation.Lysophosphatidic acid stimulates osteoclast fusion through OC-STAMP and P2X7 receptor signaling.Effect of Icariin on Tibial Dyschondroplasia Incidence and Tibial Characteristics by Regulating P2RX7 in Chickens.
P2860
Q24617046-436CB560-80EC-4CF5-9C89-B8E5DC93C84EQ24634398-AAB7B81F-4B66-4D07-B380-3EE4D15A8014Q24655197-C848798C-DDF5-4144-94DC-C6C68B3E540EQ27500363-A3B9A109-04E7-4FF3-9702-10EAD6613682Q33636713-0541D874-AC2E-4C08-9965-397D2F2DC2C5Q34036039-DAC3E7AB-4D6D-41EA-9D4F-CFA743ABD9AEQ34195588-1C779490-5B99-4B34-BFC7-21BA47A351B8Q35969039-6EDB5F3E-8BC2-4F2D-8759-C4FF34979A5FQ36167441-BFBEBFB8-AFCA-4715-AB72-FDA29C2AC212Q36183615-D5150EE9-32CF-480C-85B3-FAC6057F8B47Q36200053-0A879AB9-DBF2-4D6C-94BC-3B44898B513BQ36568421-4590FD14-949A-483A-82D9-B31B9B4CCCB0Q37203211-F2C68C63-8B3B-478A-904C-F3A401650563Q37468714-DCDA6D3F-C9B2-495E-B60B-EEE3B1114165Q38885851-33197AA5-F127-463A-BE45-28DA7C85AFCAQ39882281-3D96A28C-3868-4F21-9A95-DD8499C74391Q39885707-1D080CCC-EEC6-4AEC-84B9-0192707506F6Q40281610-7E03E96F-BAE6-4065-8316-D6733F364D2BQ40730190-E968FA20-0DCC-44BF-890B-9DDF76D6D2E2Q42106964-3F0D1B1F-5FAB-419B-B97A-E6DAD39A3929Q42218153-475E78AD-F392-4968-B570-C8964007F605Q42576613-35F8C5FF-E91C-4CC2-BD49-8E8BB310FCC9Q43147672-0E6CCA44-FCEB-4BC7-8082-FE79BCDF50E2Q46802550-6785E3BA-B0F8-485A-B1BB-DD2AD0E9B8CEQ48106641-0B53D96E-8337-4F14-A042-0064ED755B05Q50448979-F1910367-9D49-4126-B2E2-8141A3D044D5Q51035107-69203B17-9CB7-42D5-B945-CA070EAEC127Q55092579-03F9564C-0805-43B6-B062-D222C1C1FC78
P2860
Blockade of the pore-forming P2X7 receptor inhibits formation of multinucleated human osteoclasts in vitro
description
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2003
@ast
im Oktober 2003 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: October 2003)
@en
vedecký článok (publikovaný 2003-10)
@sk
vědecký článek publikovaný v roce 2003
@cs
wetenschappelijk artikel (gepubliceerd in 2003-10)
@nl
наукова стаття, опублікована в жовтні 2003
@uk
مقالة علمية (نشرت في أكتوبر 2003)
@ar
name
Blockade of the pore-forming P ...... ted human osteoclasts in vitro
@ast
Blockade of the pore-forming P ...... ted human osteoclasts in vitro
@en
Blockade of the pore-forming P ...... ted human osteoclasts in vitro
@nl
type
label
Blockade of the pore-forming P ...... ted human osteoclasts in vitro
@ast
Blockade of the pore-forming P ...... ted human osteoclasts in vitro
@en
Blockade of the pore-forming P ...... ted human osteoclasts in vitro
@nl
prefLabel
Blockade of the pore-forming P ...... ted human osteoclasts in vitro
@ast
Blockade of the pore-forming P ...... ted human osteoclasts in vitro
@en
Blockade of the pore-forming P ...... ted human osteoclasts in vitro
@nl
P2093
P1476
Blockade of the pore-forming P ...... ted human osteoclasts in vitro
@en
P2093
A Gartland
J A Gallagher
K A Buckley
W B Bowler
P2888
P356
10.1007/S00223-002-2098-Y
P407
P577
2003-10-01T00:00:00Z
P5875
P6179
1032117956